Banka Bioloo

how big is Banka Bioloo?

As of Jun 06, Banka Bioloo Ltd has a market capitalization of 72.00 Cr, with net sales of 54.18 Cr and a net profit of -8.92 Cr over the latest four quarters. Shareholder's funds are 39.72 Cr, and total assets amount to 77.42 Cr as of Mar'24.

Market Cap: As of Jun 06, Banka Bioloo Ltd has a market capitalization of 72.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the sum of Net Sales is 54.18 Cr, while the sum of Net Profit is -8.92 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 39.72 Cr, and Total Assets amount to 77.42 Cr.

What does Banka Bioloo do?

Banka Bioloo Ltd specializes in sanitation infrastructure and waste treatment solutions, operating as a Micro Cap company. As of March 2025, it reported net sales of 15 Cr and a net loss of 2 Cr, with a market cap of Rs 69 Cr.

Overview: <BR>Banka Bioloo Ltd provides sanitation infrastructure and hygienic solutions for human waste treatment and disposal, operating within the Industrial Manufacturing industry and classified as a Micro Cap company.<BR><BR>History: <BR>Banka Bioloo Ltd was incorporated as a Private Limited Company on August 31, 2012, and later changed its status to a Public Limited Company on November 15, 2017. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 15 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 69 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.95 <BR>Return on Equity: -27.29% <BR>Price to Book: 2.24<BR><BR>Contact Details: <BR>Address: Plot No.11-4-651 A-109 Express, Apartment Lakdi Ka Pool Hyderabad Telangana : 500004 <BR>Tel: 91-40-29801495 <BR>Email: info@bankabio.com <BR>Website: http://www.bankabio.com

When is the next results date for Banka Bioloo?

No Upcoming Board Meetings

What is the bonus history of the Banka Bioloo?

Banka Bioloo issued a 3:2 bonus on September 8, 2020, with a record date of September 9, 2020, meaning shareholders received three shares for every two shares held.

Banka Bioloo has a bonus history that includes a 3:2 bonus issue announced with an ex-date of September 8, 2020. The record date for this bonus was September 9, 2020. This means that for every two shares held, shareholders received three shares as part of this bonus issue.

Has Banka Bioloo declared dividend?

Banka Bioloo Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 8, 2020. Despite the dividend declaration, the dividend yield is 0%, and total returns have been negative in the short to medium term, though there was a significant positive return of 601.54% over five years.

Banka Bioloo Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 08 Sep 2020<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -40.14%, the dividend return was 0%, resulting in a total return of -40.14%.<BR><BR>In the 1-year period, the price return was -37.97%, the dividend return was 0%, leading to a total return of -37.97%.<BR><BR>In the 2-year period, the price return was -10.66%, the dividend return was 0%, which resulted in a total return of -10.66%.<BR><BR>In the 3-year period, the price return was -11.59%, the dividend return was 0%, culminating in a total return of -11.59%.<BR><BR>In the 4-year period, the price return was -14.44%, the dividend return was 0%, resulting in a total return of -14.44%.<BR><BR>In the 5-year period, the price return was 601.54%, the dividend return was 0%, leading to a total return of 601.54%.<BR><BR>Overall, while Banka Bioloo Ltd has declared a dividend, the dividend yield remains at 0%. The total returns over various periods show significant negative returns in the short to medium term, but a substantial positive return over the five-year period.

Who are the peers of the Banka Bioloo?

Banka Bioloo's peers include Kaynes Tech, Honeywell Auto, Jyoti CNC Auto, LMW, Jupiter Wagons, and others. In terms of management risk, growth, and capital structure, Kaynes Tech and Jyoti CNC Auto perform well, while Banka Bioloo shows below-average growth and a 1-year return of 0.00%.

Peers: The peers of Banka Bioloo are Kaynes Tech, Honeywell Auto, Jyoti CNC Auto., LMW, Jupiter Wagons, Solitaire Mach., Manugraph India, Rasi Electrodes, Meera Industries, and Vruddhi Engineer.<BR><BR>Quality Snapshot: Excellent management risk is observed at Honeywell Auto, Jyoti CNC Auto., and Solitaire Mach., while Good management risk is found at Kaynes Tech and Vruddhi Engineer. Average management risk is present at LMW, Jupiter Wagons, and the rest. Below Average management risk is noted at Manugraph India, Rasi Electrodes, and Meera Industries. In terms of growth, Excellent growth is seen at Kaynes Tech, Jyoti CNC Auto., Jupiter Wagons, and Vruddhi Engineer, while Below Average growth is found at Honeywell Auto, LMW, Solitaire Mach., Manugraph India, Rasi Electrodes, Meera Industries, and Banka Bioloo. Good capital structure is present at Honeywell Auto, Jyoti CNC Auto., Jupiter Wagons, and Rasi Electrodes, while Excellent capital structure is noted at LMW and Solitaire Mach., and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kaynes Tech at 65.93%, while the peer with the lowest is Honeywell Auto at -26.32%. Banka Bioloo's 1-year return is 0.00%, which is lower than both of these peers. Additionally, the peers with negative six-month returns include Kaynes Tech, Honeywell Auto, LMW, Jupiter Wagons, Rasi Electrodes, and Vruddhi Engineer.

Is Banka Bioloo overvalued or undervalued?

As of November 18, 2024, Banka Bioloo Ltd. is considered overvalued and risky due to negative financial ratios and significant underperformance compared to its peers and the Sensex.

As of 18 November 2024, the valuation grade for Banka Bioloo Ltd. has moved from fair to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued based on several key ratios, including a PE ratio of -8.02, an EV to EBITDA ratio of -34.51, and a ROE of -27.29%. These figures suggest that the company is struggling to generate profits and is facing substantial financial challenges.<BR><BR>In comparison to its peers, Banka Bioloo's valuation metrics are concerning. For instance, while the company has a negative PE ratio, its peer group shows more favorable valuations, which raises questions about its market position. The stock has underperformed significantly against the Sensex, with a year-to-date return of -34.96% compared to the Sensex's 6.25%. Overall, the combination of negative financial ratios and poor stock performance suggests that Banka Bioloo is overvalued in the current market environment.

What is the technical trend for Banka Bioloo?

As of June 2, 2025, Banka Bioloo's technical trend is bearish, supported by bearish signals from moving averages, Bollinger Bands, and the KST, despite a mildly bullish weekly MACD.

As of 2 June 2025, the technical trend for Banka Bioloo has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is mildly bullish, but the monthly MACD indicates a bearish trend. Both the weekly and monthly Bollinger Bands confirm a bearish outlook. Daily moving averages are also bearish, reinforcing the negative sentiment. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, while the Dow Theory and OBV both reflect a mildly bearish stance in both time frames. Overall, the combination of these indicators suggests a bearish trend for Banka Bioloo.

Who are in the management team of Banka Bioloo?

As of March 2022, the management team of Banka Bioloo includes Sanjay Banka (Chairman/ED & CEO), Namita Banka (ED/MD/Promoter), and several other executive and independent directors, totaling ten members who guide the company's governance and strategy.

As of March 2022, the management team of Banka Bioloo includes:<BR><BR>1. **Sanjay Banka** - Chairman/ED & CEO<BR>2. **Namita Banka** - ED / MD / Promoter<BR>3. **Vishal Murarka** - Executive Director & CEO<BR>4. **Akhilesh Kumar Tripathi** - Executive Director<BR>5. **T V Rama Krishna** - Executive Director & CFO<BR>6. **Sanjay Kumar Gangwar** - Independent Non-Executive Director<BR>7. **Kamalesh Sekhar** - Independent Non-Executive Director<BR>8. **Basava Raju Dumpala** - Independent Non-Executive Director<BR>9. **Aparjit Agarwal** - Independent Non-Executive Director<BR>10. **Anil Sharma** - Independent Non-Executive Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the company's governance and strategic direction.

Who are the top shareholders of the Banka Bioloo?

The top shareholders of Banka Bioloo include Namita Sanjay Banka with 30.2%, Akhilesh Kumar Tripathi at 3.93%, and individual investors collectively holding 37.82%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of Banka Bioloo include Namita Sanjay Banka, who is the promoter with the highest holding at 30.2%. The highest public shareholder is Akhilesh Kumar Tripathi, holding 3.93%. Additionally, individual investors collectively hold 37.82% of the shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

How has been the historical performance of Banka Bioloo?

Banka Bioloo has experienced revenue growth from 30.46 Cr in March 2021 to 54.17 Cr in March 2025, but has faced significant losses, with profit after tax dropping to -8.94 Cr and operating profit turning negative at -2.55 Cr. Total liabilities and assets have increased, while cash flow from operations declined to 0.00 Cr, indicating deteriorating profitability and cash generation.

Answer:<BR>The historical performance of Banka Bioloo shows a fluctuating trend in key financial metrics over the years leading up to March 2025.<BR><BR>Breakdown:<BR>Banka Bioloo's net sales have increased from 30.46 Cr in March 2021 to 54.17 Cr in March 2025, indicating a positive growth trajectory. However, total expenditure has also risen significantly, reaching 57.05 Cr in March 2025, up from 27.05 Cr in March 2021. This has resulted in an operating profit (PBDIT) that turned negative at -2.55 Cr in March 2025, compared to a positive 9.13 Cr in March 2020. The company has faced increasing losses, with profit before tax dropping to -9.15 Cr in March 2025 from a profit of 7.85 Cr in March 2020. Consequently, the profit after tax also fell to -8.94 Cr in March 2025, down from 6.23 Cr in March 2020. The total liabilities have increased from 46.36 Cr in March 2021 to 82.16 Cr in March 2025, while total assets have similarly risen to 82.16 Cr in March 2025 from 46.36 Cr in March 2021. Cash flow from operating activities has been inconsistent, with a notable decline to 0.00 Cr in March 2025, reflecting challenges in generating cash from core operations. Overall, while revenue growth is evident, the company's profitability and cash flow have deteriorated significantly in recent years.

Are Banka Bioloo Ltd latest results good or bad?

Banka Bioloo Ltd's latest results show record revenue growth but continued net losses, marking the seventh consecutive quarter of negative earnings. While there are improvements in operating margins, persistent profitability challenges and high leverage indicate a cautious outlook for investors.

Banka Bioloo Ltd's latest results present a mixed picture. On one hand, the company achieved a record revenue of ₹15.26 crores in Q3 FY26, marking a significant 17.29% quarter-on-quarter increase and an 8.69% year-on-year growth. This indicates improving demand for its sanitation solutions and suggests some operational momentum.<BR><BR>However, the company continues to face persistent challenges with profitability. It reported a net loss of ₹0.15 crores for the quarter, although this is an 86.11% improvement from the previous quarter's loss of ₹1.08 crores. Despite this narrowing of losses, it marks the seventh consecutive quarter of negative earnings, raising concerns about its ability to achieve sustainable profitability.<BR><BR>Additionally, the operating margin improved to 9.50%, the highest in recent quarters, but the overall financial health remains precarious, with a low return on equity of 1.94% and significant leverage indicated by a debt-to-EBITDA ratio of 7.90 times. These factors contribute to a challenging outlook for the company.<BR><BR>In summary, while there are positive signs in terms of revenue growth and improved margins, the ongoing losses and structural financial issues suggest that the results are more concerning than encouraging. Investors should be cautious given the company's fundamental challenges.

Should I buy, sell or hold Banka Bioloo Ltd?

Why is Banka Bioloo Ltd falling/rising?

As of 18-Apr, Banka Bioloo Ltd's stock price is currently at 73.06, reflecting a decrease of 1.12, or 1.51%. The decline is mainly due to weak fundamental performance, negative operating profits, and underperformance compared to sector benchmarks, despite recent gains.

As of 18-Apr, Banka Bioloo Ltd's stock price is currently at 73.06, reflecting a decrease of 1.12, or 1.51%. This decline can be attributed to several factors highlighted in the provided data. <BR><BR>Despite a strong performance over the past week and month, where the stock has risen by 5.72% and 51.45% respectively, it is underperforming today by 3.96% compared to its sector. The stock's current price is lower than its 200-day moving average, indicating a potential bearish trend. Additionally, the company has shown weak long-term fundamental strength, with a staggering -175.95% compound annual growth rate (CAGR) in operating profits over the last five years and a high debt to EBITDA ratio of 32.39 times, suggesting significant challenges in servicing its debt.<BR><BR>Moreover, the company has recorded negative operating profits, with an EBIT of Rs. -1.16 crore, and while profits have risen by 60.7% over the past year, the stock itself has generated a return of -1.74%. This combination of negative operating results and weak profitability per unit of shareholders' funds, indicated by a low average return on equity of 1.94%, contributes to the stock's current downward movement. <BR><BR>In summary, the stock's decline is primarily driven by its weak fundamental performance, negative operating profits, and underperformance relative to sector benchmarks, despite some recent gains.

Which are the latest news on Banka Bioloo?